RXULTI
Film-coated tablet
Compare
|
EU/1/18/1294/007
Authorised: 26/07/2018
Otsuka Pharmaceutical Netherlands B.V.
|
SPC
PIL
IPAR
|
RXULTI
Film-coated tablet
Compare
|
EU/1/18/1294/003-004
Authorised: 26/07/2018
Otsuka Pharmaceutical Netherlands B.V.
|
SPC
PIL
IPAR
|
RXULTI
Film-coated tablet
Compare
|
EU/1/18/1294/001
Authorised: 26/07/2018
Otsuka Pharmaceutical Netherlands B.V.
|
SPC
PIL
IPAR
|
RXULTI
Film-coated tablet
Compare
|
EU/1/18/1294/005
Authorised: 26/07/2018
Otsuka Pharmaceutical Netherlands B.V.
|
SPC
PIL
IPAR
|
RXULTI
Film-coated tablet
Compare
|
EU/1/18/1294/002
Authorised: 26/07/2018
Otsuka Pharmaceutical Netherlands B.V.
|
SPC
PIL
IPAR
|
RXULTI
Film-coated tablet
Compare
|
EU/1/18/1294/006
Authorised: 26/07/2018
Otsuka Pharmaceutical Netherlands B.V.
|
SPC
PIL
IPAR
|
Ryaltris 25 microgram/actuation + 600 microgram/actuation nasal spray, suspension
Nasal spray, suspension
Compare
|
PA1543/002/001
Authorised: 16/07/2021
Glenmark Pharmaceuticals s.r.o.
|
SPC
PIL
|
Rybelsus
Tablet
Compare
|
EU/1/20/1430/008-010
Authorised: 03/04/2020
Novo Nordisk A/S
|
SPC
PIL
IPAR
|
Rybelsus
Tablet
Compare
|
EU/1/20/1430/001-004
Authorised: 03/04/2020
Novo Nordisk A/S
|
SPC
PIL
IPAR
|
Rybelsus
Tablet
Compare
|
EU/1/20/1430/005-007
Authorised: 03/04/2020
Novo Nordisk A/S
|
SPC
PIL
IPAR
|
Rybrevant
Concentrate for solution for infusion
Compare
|
EU/1/21/1594/001
Authorised: 09/12/2021
Janssen-Cilag International NV
|
SPC
PIL
IPAR
|
Rybrila 160 micrograms/ml Oral Solution
Oral solution
Compare
|
PA22701/001/001
Authorised: 23/07/2021
Clinigen Healthcare B.V.
|
SPC
PIL
EdM
|
Rydapt
Capsule, soft
Compare
|
EU/1/17/1218/001
Authorised: 18/09/2017
Novartis Europharm Limited
|
SPC
PIL
IPAR
|
Ryeqo
Film-coated tablet
Compare
|
EU/1/21/1565/001-002
Authorised: 16/07/2021
Gedeon Richter Plc
|
SPC
PIL
IPAR
|
Ryzodeg
Solution for injection
Compare
|
EU/1/12/806/1,4,5,7,8
Novo Nordisk A/S
|
SPC
PIL
IPAR
|